Strategies to increase limited donor resources

European Respiratory Journal

Volumn 23, Issue 3, 2004, Pages 477-482

  de Perrot, M ^a   Weder, W ^b   Patterson, G A ^c   Keshavjee, Shaf ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Donor; Graft failure; Lung; Preservation; Reperfusion injury; Transplantation

Indexed keywords

BODY SIZE; CADAVER DONOR; HUMAN; LIVING DONOR; LUNG RESECTION; LUNG TRANSPLANTATION; ORGAN DONOR; ORGAN PRESERVATION; OUTCOMES RESEARCH; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SURGICAL TECHNIQUE;

AGE FACTORS; HUMANS; LIVING DONORS; LUNG TRANSPLANTATION; ORGAN PRESERVATION; RESUSCITATION; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 0242390070     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00094504     Document Type: Review

References (65)

1. Hertz M, Taylor D, Trulock E, et al. The Registry of the International Society for Heart and Lung Transplantation: Nineteenth official report - 2002. J Heart Lung Transplant 2002; 21: 950-970.
2. Fisher AJ, Dark JH, Corris PA. Improving donor lung evaluation: A new approach to increase organ supply for lung transplantation. Thorax 1998; 53: 818-820.
3. Lucas BA, Vaughn WK, Spees EK, Sanfilippo F. Identification of donor factors predisposing to high discard rates of cadaver kidneys and increased graft loss within one year posttransplantation - SEOPF 1977-1982. South-Eastern Organ Procurement Foundation. Transplantation 1987; 43: 253-258.
4. Busuttil RW, Goldstein LI, Danovitch GM, Ament ME, Memsic LD. Liver transplantation today. Ann Intern Med 1986; 104: 377-389.
5. Wicomb WN, Cooper DK, Lanza RP, Novitzky D, Isaacs S. The effects of brain death and 24 hours' storage by hypothermic perfusion on donor heart function in the pig. J Thorac Cardiovasc Surg 1986; 91: 896-909.
6. Pennefather SH, Bullock RE, Dark JH. The effect of fluid therapy on alveolar arterial oxygen gradient in brain-dead organ donors. Transplantation 1993; 56: 1418-1422.
7. Mertes PM, el Abassi K, Jaboin Y, et al. Changes in hemodynamic and metabolic parameters following induced brain death in the pig. Transplantation 1994; 58: 414-418.
8. Zaroff JG, Rosengard BR, Armstrong WF, et al. Maximizing use of organs recovered from the cadaver donor: Cardiac recommendations. March 28-29, 2001, Crystal City, VA. J Heart Lung Transplant 2002; 21: 1153-1160.
9. Ware LB, Fang X, Wang Y, Sakuma T, Hall TS, Matthay MA. Selected contribution: Mechanisms that may stimulate the resolution of alveolar edema in the transplanted human lung. J Appl Physiol 2002; 93: 1869-1874.
10. Katz K, Lawler J, Wax J, O'Connor R, Nadkarni V. Vasopressin pressor effects in critically ill children during evaluation for brain death and organ recovery. Resuscitation 2000; 47: 33-40.
11. Pennefather SH, Bullock RE, Mantle D, Dark JH. Use of low dose arginine vasopressin to support brain-dead organ donors. Transplantation 1995; 59: 58-62.
12. Iwai A, Sakano T, Uenishi M, Sugimoto H, Yoshioka T, Sugimoto T. Effects of vasopressin and catecholamines on the maintenance of circulatory stability in brain-dead patients. Transplantation 1989; 48: 613-617.
13. Chen JM, Cullinane S, Spanier TB, et al. Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation 1999; 100: Suppl. 19, II244-II246.
14. Gramm HJ, Meinhold H, Bickel U, et al. Acute endocrine failure after brain death? Transplantation 1992; 54: 851-857.
15. Howlett TA, Keogh AM, Perry L, Touzel R, Rees LH. Anterior and posterior pituitary function in brain-stem-dead donors. A possible role for hormonal replacement therapy. Transplantation 1989; 47: 828-834.
16. Chen EP, Bittner HB, Kendall SW, van Trigt P. Hormonal and hemodynamic changes in a validated animal model of brain death. Crit Care Med 1996; 24: 1352-1359.
17. Wheeldon DR, Potter CD, Oduro A, Wallwork J, Large SR. TOansforDing the "uNacceptable" donor: outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant 1995; 14: 734-742.
18. Cooper DK, Novitzky D, Wicomb WN. The pathophysiological effects of brain death on potential donor organs, with particular reference to the heart. Ann R Coll Surg Engl 1989; 71: 261-266.
19. Follette DM, Rudich SM, Babcock WD. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant 1998; 17: 423-429.
20. McElhinney DB, Khan JH, Babcock WD, Hall TS. Thoracic organ donor characteristics associated with successful lung procurement. Clin Transplant 2001; 15: 68-71.
21. Washida M, Okamoto R, Manaka D, et al. Beneficial effect of combined 3,5,3′-triiodothyronine and vasopressin administration of hepatic energy status and systemic hemodynamics after brain death. Transplantation 1992; 54: 44-49.
22. Salim A, Vassiliu P, Velmahos GC, et al. The role of thyroid hormone administration in potential organ donors. Arch Surg 2001; 136: 1377-1380.
23. Novitzky D, Cooper DK, Chaffin JS, Greer AE, DeBault LE, Zuhdi N. Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient. Transplantation 1990; 49: 311-316.
24. Totsuka E, Dodson F, Urakami A, et al. Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: Effect of correction of donor hypernatremia. Liver Transpl Surg 1999; 5: 421-428.
25. Markmann JF, Markmann JW, Markmann DA, et al. Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants. Transplantation 2001; 72: 1113-1122.
26. de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion induced lung injury. Am J Respir Crit Care Med 2003; 167: 490-511.
27. Fischer S, Matte-Martyn A, de Perrot M, et al. Low-potassium dextran preservation solution improves lung function after human lung transplantation. J Thorac Cardiovasc Surg 2001; 121: 594-596.
28. Struber M, Wilhelmi M, Harringer W, et al. Flush perfusion with low potassium dextran solution improves early graft function in clinical lung transplantation. Eur J Cardiothorac Surg 2001; 19: 190-194.
29. Muller C, Furst H, Reichenspurner H, Briegel J, Groh J, Reichart B. Lung procurement by low-potassium dextran and the effect on preservation injury. Munich Lung Transplant Group. Transplantation 1999; 68: 1139-1143.
30. Rega F, Verleden G, Vanhaecke J, Daenen W, Van Raemdonck D. Switch from Euro-Collins to Perfadex for pulmonary graft preservation resulted in superior outcome in transplant recipients. J Heart Lung Transplant 2003; 22: Suppl. 1, A117.
31. Aziz TM, Pillay TM, Corris PA, et al. Perfadex for clinical lung procurement: Is it an advance? Ann Thorac Surg 2003; 75: 1960-1964.
32. Thabut G, Vinatier I, Brugiere O, et al. Influence of preservation solution on early graft failure in clinical lung transplantation. Am J Respir Crit Care Med 2001; 164: 1204-1208.
33. Baretti R, Bitu-Moreno J, Beyersdorf F, Matheis G, Francischetti I, Kreitmayr B. Distribution of lung preservation solutions in parenchyma and airways: Influence of atelectasis and route of delivery. J Heart Lung Transplant 1995; 14: 80-91.
34. Chen CZ, Gallagher RC, Ardery P, Dyckman W, Low HB. Retrograde versus antegrade flush in canine left lung preservation for six hours. J Heart Lung Transplant 1996; 15: 395-403.
35. Varela A, Montero CG, Cordoba M, et al. Improved distribution of pulmonary flush solution to the tracheobronchial wall in pulmonary transplantation. Eur Surg Res 1997; 29: 1-4.
36. Wittwer T, Fehrenbach A, Meyer D, et al. Retrograde flush perfusion with low-potassium solutions for improvement of experimental pulmonary preservation. J Heart Lung Transplant 2000; 19: 976-983.
37. Varela A, Cordoba M, Serrano-Fiz S, et al. Early lung allograft function after retrograde and antegrade preservation. J Thorac Cardiovasc Surg 1997; 114: 1119-1120.
38. Venuta F, Rendina EA, Bufi M, et al. Preimplantation retrograde pneumoplegia in clinical lung transplantation. J Thorac Cardiovasc Surg 1999; 118: 107-114.
39. Pierre AF, DeCampos KN, Liu M, et al. Rapid reperfusion causes stress failure in ischemic rat lungs. J Thorac Cardiovasc Surg 1998; 116: 932-942.
40. de Perrot M, Imai Y, Volgyesi GA, et al. Effect of ventilator-induced lung injury on the development of reperfusion injury in a rat lung transplant model. J Thorac Cardiovasc Surg 2002; 124: 1137-1144.
41. McRae KM. Pulmonary transplantation. Curr Opin Anesthesiol 2000; 13: 53-59.
42. Sundaresan S, Semenkovich J, Ochoa L, et al. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg 1995; 109: 1075-1079.
43. Bhorade SM, Vigneswaran W, McCabe MA, Garrity ER. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant 2000; 19: 1199-1204.
44. Gabbay E, Williams TJ, Griffiths AP, et al. Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med 1999; 160: 265-271.
45. Kron IL, Tribble CG, Kern JA, et al. Successful transplantation of marginally acceptable thoracic organs. Ann Surg 1993; 217: 518-522.
46. Sundaresan S, Trachiotis GD, Aoe M, Patterson GA, Cooper JD. Donor lung procurement: Assessment and operative technique. Ann Thorac Surg 1993; 56: 1409-1413.
47. Pierre AF, Sekine Y, Hutcheon MA, Waddell TK, Keshavjee SH. Marginal donor lungs: A reassessment. J Thorac Cardiovasc Surg 2002; 123: 421-428.
48. de Perrot M, Sekine Y, Fischer S, et al. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med 2002; 165: 211-215.
49. Weill D, Dey GC, Hicks RA, et al. A positive donor gram stain does not predict outcome following lung transplantation. J Heart Lung Transplant 2002; 21: 555-558.
50. Dowling RD, Zenati M, Yousem SA, et al. Donor-transmitted pneumonia in experimental lung allografts. Successful prevention with donor antibiotic therapy. J Thorac Cardiovasc Surg 1992; 103: 767-772.
51. Straznicka M, Follette DM, Eisner MD, Roberts PF, Menza RL, Babcock WD. Aggressive management of lung donors classified as unacceptable: Excellent recipient survival one year after transplantation. J Thorac Cardiovasc Surg 2002; 124: 250-258.
52. Starnes VA, Barr ML, Cohen RG, et al. Living donor lobar lung transplantation experience: Intermediate results. J Thorac Cardiovasc Surg 1996; 112: 1284-1290.
53. Starnes VA, Barr ML, Woo M. A decade of living lobar transplantation: Recipient outcomes. J Thorac Cardiovasc Surg 2004; (in press).
54. Starnes VA, Barr ML, Schenkel FA, et al. Experience with living donor lobar transplantation for indications other than cystic fibrosis. J Thorac Cardiovasc Surg 1997; 114: 917-921.
55. Date H, Nagahiro I, Aoe M, et al. Living donor lobar lung transplantation for primary pulmonary hypertension in an adult. J Thorac Cardiovasc Surg 2001; 122: 817-818.
56. Date H, Sano Y, Aoe M, et al. Living donor lobar lung transplantation for bronchiolitis obliterans after Stephens Johnson syndrome. J Thorac Cardiovasc Surg 2002; 123: 389-391.
57. Battafarano RJ, Anderson RC, Meyers BF, et al. Perioperative complications after living donor lobectomy. J Thorac Cardiovasc Surg 2000; 120: 909-915.
58. Egan TM, Lambert CJ, Reddick R, Ulicny KS Jr, Keagy BA, Wilcox BR. A strategy to increase the donor pool: Use of cadaver lungs for transplantation. Ann Thorac Surg 1991; 52: 1113-1121.
59. Van Raemdonck DEM, Jannis NCP, De Leyn PRJ, Flameng WJ, Lerut TE. Warm ischemic tolerance in collapsed pulmonary grafts is limited to one hour. Ann Surg 1998; 228: 788-796.
60. Steen S, Sjoberg T, Ingemansson R, Lindberg L. Efficacy of topical cooling in lung preservation: Is a reappraisal due? Ann Thorac Surg 1994; 58: 1657-1663.
61. Steen S, Sjoberg T, Pierre L, Liao Q, Eriksson L, Algotsson L. Transplantation of lungs from a non-heart beating donor. Lancet 2001; 357: 825-829.
62. Wisser W, Klepetko W, Wekerle T, et al. Tailoring of the lung to overcome size disparities in lung transplantation. J Heart Lung Transplant 1996; 15: 239-242.
63. Couetil JP, Grousset A, Tolan MJ, Benaim A, Fayolle P, Carpentier A. Experimental bilateral lobar lung transplantation and its application in the human. Thorax 1997; 52: 714-717.
64. Couetil JP, Tolan MJ, Loulmet DF, et al. Pulmonary bipartitioning and lobar transplantation: A new approach to donor organ shortage. J Thorac Cardiovasc Surg 1997; 113: 529-537.
65. Artermiou O, Birsan T, Taghavi S, et al. Bilateral lobar transplantation with the split lung technique. J Thorac Cardiovasc Surg 1999; 118: 369-370.